WaferGen Biosystems Revenue and Competitors

NOW PART OF TAKARA BIO USA, INC. -- Please visit the Takara Bio USA, Inc. company page for the latest updates: https://www.linkedin.com/company-beta/17509/ WaferGen automation systems include innovative genomic technology solutions for single-cell analysis and clinical research. The ICELL8® Single-Cell System is a revolutionary platform which can isolate thousands of single cells and enables selection and processing of specific cells for various analysis methods, including next generation sequencing. The system has demonstrated unbiased isolation of up to 1,800 single cells 5–100 µm in size on a single chip, including cells from solid tumors and brain tissues, pulmonary airway cells, and multiple cell lines. The SmartChip™ platform can be used for profiling and validating molecular biomarkers, and can perform massively parallel singleplex PCR for one-step NGS library preparation in clinical applications. The Apollo™ 324 system can be used to process DNA and RNA obtained from clinical samples into NGS-ready libraries. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell levels in the life sciences, pharmaceutical, and clinical laboratory industries.